Structure-based model of SARS-CoV-2 spike protein reveals opportunity to halt virus transmission
Scientists have simulated the transition of the SARS-CoV-2 spike protein structure from when it recognizes the host cell to when
Read more
SARS-CoV-2 Delta variant associated with more breakthrough infections
A US-based study conducted in the National Capital Region has recently compared the infectious virus loads in vaccinated and unvaccinated
Read more
SARS-CoV-2 Spike may trigger production of antibodies that cross-react with human thrombopoietin to induce thrombocytopenia
Scientists have stated that molecular mimicry between human proteins and pathogens can incorrectly lead to antibodies attacking human proteins. Such
Read more
Nasal version of AstraZeneca SARS-CoV-2 vaccine prevents infection in animal models
The causal agent of the current coronavirus disease 2019 (COVID-19) pandemic is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Read more
Emerging SARS-CoV-2 mutations L452R & Y453F evade cellular immunity
The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally, with the
Read more
Human tissue xenografts in murine models for the study of SARS-CoV-2
Severe COVID-19 is associated with massive dysregulation of the host immune response, resulting in inflammation and the condition known as
Read more
Antibody levels remain high nine months after SARS-CoV-2 infection, study shows
Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.
Read more
SARS-CoV-2 Lambda variant spreading rapidly in South America, report reveals
A new research paper by researchers in Peru describes a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Read more
Zinc-embedded polyamides inactivate SARS-CoV-2 and influenza A
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A viruses (IAVs) can spread via liquid droplets and aerosols. These
Read more
REGEN-COV antibody cocktail shown to significantly lower SARS-CoV-2 viral load
The phase 1/2 trial of the REGEN-COV (casirivimab and imdevimab) antibody cocktail from Regeneron conducted on 799 individuals shows that
Read more